YWHAE/14-3-3ε: a potential novel genetic risk factor and CSF biomarker for HIV neurocognitive impairment

YWHAE (14-3-3ε) protein levels are considered to be a reliable biomarker for neurodegeneration. The YWHAE protein interacts both directly and indirectly with human immunodeficiency virus (HIV) accessory proteins, leading to cell death. The purpose of this study was to examine the relationship between YWHAE polymorphisms and HIV-associated neurocognitive disorder (HAND) and the relationship between YWHAE protein levels and HAND. A cross-sectional study using random samples of HIV-seropositive (n = 20) and HIV-seronegative (controls) (n = 16) women from the Hispanic-Latino Longitudinal Cohort of Women was conducted. Individuals who are HIV-seropositive and heterozygous at the rs4790084/rs1204828 loci in the YWHAE gene were 3× more likely to display reduced cognitive functioning, to have received a HAND diagnosis, and to have less YHWAE protein expressed than homozygotes. Western blots from cerebral spinal fluid indicate that the HIV-seropositive women with HAND expressed 4.5× less YWHAE compared to HIV-seropositive cognitively normal women (94 % sensitivity, 84 % specificity; HIV-seropositive vs. controls). Therefore, polymorphism in YWHAE may be a genetic risk factor for HAND and levels of YWHAE protein are a likely biomarker for neurocognitive status in HIV-seropositive women.

[1]  M. Kogan,et al.  HIV-1 Accessory Protein Vpr: Relevance in the pathogenesis of HIV and potential for therapeutic intervention , 2011, Retrovirology.

[2]  D. Berg,et al.  14-3-3 proteins in the nervous system , 2003, Nature Reviews Neuroscience.

[3]  H. Gendelman,et al.  Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment , 2003, Neurology.

[4]  H. Kretzschmar,et al.  Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD? , 2006, BMC neurology.

[5]  N. Barbaro,et al.  Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. , 2003, Archives of neurology.

[6]  Kai-lai Sun,et al.  14-3-3epsilon contributes to tumour suppression in laryngeal carcinoma by affecting apoptosis and invasion , 2010, BMC Cancer.

[7]  Kimberley A Walsh,et al.  Human CNS cultures exposed to HIV-1 gp120 reproduce dendritic injuries of HIV-1-associated dementia , 2004, Journal of Neuroinflammation.

[8]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[9]  M. Masuda,et al.  HIV-1 Vpr induces G2 cell cycle arrest in fission yeast associated with Rad24/14-3-3-dependent, Chk1/Cds1-independent Wee1 upregulation. , 2006, Microbes and infection.

[10]  M. Yaffe,et al.  14-3-3 proteins as signaling integration points for cell cycle control and apoptosis. , 2011, Seminars in cell & developmental biology.

[11]  F. Herrmann,et al.  14-3-3sigma expression and prognostic value in patients with epithelial ovarian carcinoma: a high throughput tissue microarray analysis. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[12]  H. Uno,et al.  Plasma sCD14 Is a Biomarker Associated With Impaired Neurocognitive Test Performance in Attention and Learning Domains in HIV Infection , 2011, Journal of acquired immune deficiency syndromes.

[13]  14-3-3s are potential biomarkers for HIV-related neurodegeneration , 2012, Journal of NeuroVirology.

[14]  S. Lipton.  Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. , 1992, Neuroreport.

[15]  L. Wilkins.  Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder , 1996, Neurology.

[16]  J. Berger.  Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt–Jakob disease , 2008 .

[17]  C. Gibbs,et al.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. , 1996, The New England journal of medicine.

[18]  O. Selnes,et al.  Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment , 2006, Journal of NeuroVirology.

[19]  C. Hetz,et al.  Altered Prion Protein Expression Pattern in CSF as a Biomarker for Creutzfeldt-Jakob Disease , 2012, PloS one.

[20]  H. Ushijima,et al.  Exposure to gp120 of HIV‐1 Induces an Increased Release of Arachidonic Acid in Rat Primary Neuronal Cell Culture Followed by NMDA Receptor‐mediated Neurotoxicity , 1995, The European journal of neuroscience.

[21]  S. Oka,et al.  Increased concentrations of 14-3-3 epsilon, gamma and zeta isoforms in cerebrospinal fluid of AIDS patients with neuronal destruction. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[22]  O. Selnes,et al.  Please Scroll down for Article Journal of Neurovirology Associations of Cigarette Smoking with Viral Immune and Cognitive Function in Human Immunodeficiency Virus-seropositive Women Associations of Cigarette Smoking with Viral Immune and Cognitive Function in Human Immunodeficiency Virus–seropositiv , 2022 .

[23]  B. Gelman,et al.  Synaptic Proteins Linked to HIV-1 Infection and Immunoproteasome Induction: Proteomic Analysis of Human Synaptosomes , 2009, Journal of Neuroimmune Pharmacology.

[24]  N. Philip,et al.  Deletion of YWHAE in a patient with periventricular heterotopias and pronounced corpus callosum hypoplasia , 2009, Journal of Medical Genetics.

[25]  V. Wojna,et al.  Translational spatial task and its relationship to HIV-associated neurocognitive disorders and apolipoprotein E in HIV-seropositive women , 2012, Journal of NeuroVirology.

[26]  S. Howell,et al.  14-3-3 proteins: biological function and domain structure. , 1995, Biochemical Society transactions.

[27]  A. Wynshaw-Boris,et al.  Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia. , 2008, Human molecular genetics.

[28]  Tomoshige Kino,et al.  Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1. , 2004, DNA and cell biology.

[29]  M. Lenardo,et al.  14-3-3 theta binding to cell cycle regulatory factors is enhanced by HIV-1 Vpr , 2008, Biology Direct.

[30]  G. Chrousos,et al.  HIV-1 accessory protein Vpr inhibits the effect of insulin on the Foxo subfamily of forkhead transcription factors by interfering with their binding to 14-3-3 proteins: potential clinical implications regarding the insulin resistance of HIV-1-infected patients. , 2005, Diabetes.

[31]  G. Chrousos,et al.  Vpr Protein of Human Immunodeficiency Virus Type 1 Binds to 14-3-3 Proteins and Facilitates Complex Formation with Cdc25C: Implications for Cell Cycle Arrest , 2005, Journal of Virology.

[32]  S. Oka,et al.  Increased concentrations of 14-3-3ε, γ and ζ isoforms in cerebrospinal fluid of AIDS patients with neuronal destruction , 2001 .

[33]  O. Narayan,et al.  Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain. , 1994, The Journal of biological chemistry.

[34]  J. Sodroski,et al.  Identification of HIV-1 vpr product and function. , 1990, Journal of acquired immune deficiency syndromes.

[35]  P. Silver,et al.  HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. , 1998, Genes & development.

[36]  P. Lachenbruch.  Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .

[37]  Y. Itoyama,et al.  14-3-3 protein levels and isoform patterns in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients in the progressive and terminal stages , 2006, Journal of clinical neuroscience.

[38]  D O Morgan,et al.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity , 1995, Journal of virology.

[39]  Kaitai Zhang,et al.  An Approach to Studying Lung Cancer-related Proteins in Human Blood*S , 2005, Molecular & Cellular Proteomics.

[40]  S. Rackstraw.  HIV-related neurocognitive impairment – A review , 2011, Psychology, health & medicine.

[41]  O. Narayan,et al.  Biochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein. , 1994, The Journal of biological chemistry.

[42]  Michael J. Taylor,et al.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy , 2010, Neurology.

[43]  S. Fan,et al.  Role of 14–3-3ε, c-Myc/Max, and Akt phosphorylation in HIV-1 gp 120-induced mesangial cell proliferation , 2001 .

[44]  Andrew J. Saykin,et al.  Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infection , 1991, Neurology.